Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI‐Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk‐Stratification Scoring System

Ähnliche Einträge

• Evaluation of Second‐Line Treatment for Castration‐Resistant Prostate Cancer following the Administration of Upfront Androgen Receptor Signaling Inhibitors
  von: Kazuro Kikkawa, et al.
  Veröffentlicht: (2024)
• Total en bloc spondylectomy in testicular immature teratoma: Long‐term survival amidst vertebral metastasis escalated by growing teratoma syndrome
  von: Masahiro Tamaki, et al.
  Veröffentlicht: (2024)
• A case of successful treatment of Fournier's gangrene through conservative management and elective debridement
  von: Toshifumi Takahashi, et al.
  Veröffentlicht: (2024)
• The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
  von: Trevor C. Hunt, et al.
  Veröffentlicht: (2025)
• Current Status of Prostate Biopsy in Africa: Are We Ready for a Targeted Biopsy?
  von: Ziba Ouima Justin Dieudonne, et al.
  Veröffentlicht: (2025)